Valuation: Evogene Ltd.

Market Cap 7.07M 0 6.2M 5.86M 5.34M 9.99M 677M 10.06M 70.09M 27.15M 346M 26.53M 25.96M 1.11B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 7.07M 0 6.2M 5.86M 5.34M 9.99M 677M 10.06M 70.09M 27.15M 346M 26.53M 25.96M 1.11B EV / Sales 2026 *
4.76x
EV / Sales 2027 * 2.72x
Free-Float
72.14%
Yield 2026 *
-
Yield 2027 * -
1 day-5.87%
1 week-11.43%
Current month-17.93%
1 month-16.32%
3 months+16.28%
6 months-47.76%
Current year-54.62%
1 week 134
Extreme 134
154
1 month 134
Extreme 134
173.1
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
3,700
5 years 115.1
Extreme 115.1
9,500
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 2004-11-30
Corporate Officer/Principal - -
Corporate Officer/Principal - 2021-12-31
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 2010-06-02
Chairman 60 2021-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/11/26 Buy

Director

460,000 2.9111%
8/4/26 Buy

Director

800,000 5.0628%
4/1/26 Other

Executive/Senior Manager

20,000 0.2294%
Change 5-day change 1-year change 3-year change Capi.($)
-5.87%-11.43%-64.88%-93.98% 7.07M
-0.14%+4.33%+9.00%+31.64% 47.97B
-1.69%+1.48%+50.57%+34.53% 44.5B
+2.56%+7.34%+366.69%+608.26% 43.93B
+0.24%+2.85%+10.67%+94.47% 41.03B
-0.62%-1.11%+4.65%+48.91% 29.85B
-0.28%+1.07%+24.58%+155.58% 17.27B
+3.37%+9.21%+8.32% - 15.34B
-0.46%+1.20%+26.90%+42.21% 15.3B
-2.21%-4.70% - - 14.82B
Average -0.51%+0.97%+48.50%+115.20% 27B
Weighted average by Cap. +0.11%+2.86%+79.67%+160.27%

Financials

2026 *2027 *
Net sales 1.48M 0 1.3M 1.23M 1.12M 2.1M 142M 2.11M 14.72M 5.7M 72.66M 5.57M 5.45M 234M 2.6M 0 2.28M 2.15M 1.96M 3.68M 249M 3.7M 25.79M 9.99M 127M 9.76M 9.55M 409M
Net income -16.69M -0 -14.64M -13.83M -12.6M -23.59M -1.6B -23.76M -165M -64.1M -817M -62.65M -61.3M -2.63B -13.92M -0 -12.21M -11.53M -10.51M -19.67M -1.33B -19.81M -138M -53.45M -681M -52.25M -51.12M -2.19B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
38
Date Price Change Volume
26-09-24 ILA 136.40 -5.87% 85,641
26-09-23 ILA 144.90 -0.07% 90,940
26-09-22 ILA 145.00 -5.84% 152,737

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock